{"name":"Lutris Pharma Ltd.","slug":"lutris-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LUT014 Gel","genericName":"LUT014 Gel","slug":"lut014-gel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"LUT014 Gel","genericName":"LUT014 Gel","slug":"lut014-gel","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbGdIQ3F2NzZfX1lNLTRhUUtRY2tjZ2RKaEw2SGIycmp4aXRyd2ZzWlpub0E5WUpKWFZMMlkzbGNQNEdKOWlqMlZhNGpmUnlNSjlTYW1nMjUweVpsRHRjUVhWWjJtVnBqUVpkeUNFNkxmR3ZZU0Ixa2UwWm9UVE84MEIyVkljYm1xcTNSVDI0a0hyYkU?oc=5","date":"2025-05-13","type":"trial","source":"Yahoo Finance","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for M","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNTjZGNEtXNVFxV0FucWNPSUlNMTF5XzNGZWctT2ZGMWpwT25XMURfLU1TcmRTc0s1eXNQQUdVOVRfaXppcVg3YV8wYzE1ZVZVY2toUElYakNMSHB5cXhsVTNzeGhCYVM0ckFybG1IbjRJTUtHazVHQ3BPQ0tTM0U2S0NtYzJrdGxDN1RoRQ?oc=5","date":"2025-05-12","type":"pipeline","source":"The ASCO Post","summary":"In Case You Missed It: Additional Abstracts of Interest From AACR - The ASCO Post","headline":"In Case You Missed It: Additional Abstracts of Interest From AACR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOZXlkaGtsTlJKaGdUam5GMjd5V1ZYbk1VQktWWGhJSFBPWHRXX0tUNTFDUG52dVRhMGdncS1hZmxlc2VzZm5NSkgwMUpTQXJyUFNsMG1GNHZXVTlTUHpMLUZuZmZoQVFaSDF4QU9KQmtsQjQ2cHpkRU0wTGZhd1pDUWpoSVc2M2pWejNmT1BkNEJtQ3dvN2ZYd0lJZUdmcTduWEVQbDRWX2lwRkl3VWpoV2pQS1oyLUhzdzBYSm1HanZMb0VKNmdYWGI3dmU3TXFUUlB1Zm9aSmNoOXNtbnpPeFVzVHQyS0V0U2hOaWxEOVUyLTRFZkNWSTM3WWN6VFh6emtNdGtBNl9MV1l1WkNqTA?oc=5","date":"2025-04-29","type":"pipeline","source":"PR Newswire","summary":"Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Executive Officer - PR Newswire","headline":"Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Ex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOOEloNzBMUVo2VDlxYlpXM2NsZWh0Zmgyb0dZc2dWaXJNUm9adUtqNmdKaWVIWGZnbFJrdWE3bHhZeFlMYkZfc1lpb0N3TXVRQXExTUJaQUZFWFdOTlJOQjhsYkpBM2piWEhJazBwRlpKaUs2YzN0LWFyLW1OUFFSREpRM1IzbklTVkU0Y2RSUHB6TTdnNG0zUGZMVHNnWHhhVlZMRXdwNklETXVwY0tSQ2J3am82VmpRQ2dRX2d6WHh0cGg0TGR4ZEVTb1JGYXNKX2I4S0xBcDFsSWRla1JmaXEzdHdGTVlPcXVXSXJWekRLdUNzQk1VS1YzMVVQVjE2eFZLQjB6Y2JhWFZTbWZXN2l5OFRlOEYxZ3o2ZHFHMkJuMUdZM0ltX3NJRTJSNWVZTWUybThENGFlSWh4ZWc?oc=5","date":"2025-04-23","type":"pipeline","source":"PR Newswire","summary":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - PR Newswire","headline":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQbU12OUQ1VkZ6RUYzLVR1QmNMdTNSTDREUmtTdm8xVEhYbHdKQmhVRVJ3OFFfWWt6WDRUX3dsTWd1NEdYRzFza1M5UjBOdVo2d3RNWmZQeGFyNkpiN09zRjlrSFFBRFBDb2UtS0gyRy1qc1FEQmFBQjRwS0c4VXRtVUQwcnd5Z1VDOTZGd3FNZkRPSTJ0RXR3NV9LbWVRbjB5MkhOYXNjLWVudTdmM0RmZ0FqZkU?oc=5","date":"2025-01-28","type":"pipeline","source":"Contract Pharma","summary":"Lutris Pharma Secures $30M Financing to Advance Development of LUT014 - Contract Pharma","headline":"Lutris Pharma Secures $30M Financing to Advance Development of LUT014","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNQy0zMnMzWE1uR3FUM1RYRG1RQWxkbTZGclNNSjJKem42QkpGd040b2V0aklNZ1JUM1dCQ3BhTEQwZWN3YzA1eVpma0Q3aDZweXVQcy14VGhMOVVoTTFkZmo0M0RaRE5EY0l4X3RMT2MyUUc1c0tyRTdrREFMNFpyUjBIcjIwLU9FdEV6Z1UtYm01VmJmNzJ1d3pLUkEzSUt5anNiR2FneE5KSV9DeENWOEt4Ul9IVHF1MmpHQ2tObmJVZWE0VlZDa1J4R05LZUFtRUhJM3BkRzl3UG9RNTR0YXZsUzdPekRGQlRoaGxJQl9jR1pJY0M0Vl9LbjNmZVA1R18xRExOQld6VHlzN2JGd1hGNkRoMGc?oc=5","date":"2025-01-28","type":"pipeline","source":"PR Newswire","summary":"Lutris Pharma Secures $30 Million Financing to Advance the Development of Biopharmaceutical to Improve Anti-Cancer Drug Effectiveness - PR Newswire","headline":"Lutris Pharma Secures $30 Million Financing to Advance the Development of Biopharmaceutical to Improve Anti-Cancer Drug ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQU0NrQWNRVGhLT2l4Rlo0bkNMYXhvdW02bVdrRWZNOUxfaUtCbzZpbTUzdzdNNUUxam9mMXVjSldab3NEejFCMHNtVGFzc2Q1T1B2OFVTcDMwNVpvOVhMNDZ1MjdhdVlXUE5IdzJxMnNPUkpJOGxvUi1EQ0RJMDY2Sm5WUWpiem11dWFOYUhyRUhmaUFwRlUxVml4X3pDQ05oYnBTbW8ydHQ?oc=5","date":"2024-04-08","type":"pipeline","source":"OncLive","summary":"Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC - OncLive","headline":"Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNHFNMHFORjl4MllFVmRJUkhrbzJoTG00azZnRnZHVDd0RHdrWUJNQTBwT3QzVHZQSzBRbWpGSmEwOG9FMWsyNnhQanNQeEZBR3hhNU9UaU1Nb3dJa2UtY3NrU0Z6MXYwTjlhTFB1azNMMDhSa2Rvc3RsU2w2bzVqNlVMLXdUbC1wT2pucnpQdi15LVpkSFRjdzVIeGtpaFNlYkZSaUlWdG9laEdRZEJGeVJYY1FZdmlKa19vTlhoY29hdFJEQWJFNWpaMTBjcTlVTDhTSDRmZ3RIQVItWnhYWnloVnVOWUV3RkJBSFBQWjJHcG56LXd5cGE5VQ?oc=5","date":"2024-04-01","type":"pipeline","source":"PR Newswire","summary":"Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe \"Mori\" Arkin to Its Board of Directors - PR Newswire","headline":"Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe \"Mori\" Arkin to Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPU0VValZQT1M2TUkwNU5MaHMtbVcxZ1lka2NZV1N2b3VIMFNpSzhCTXN3cVB4UTJ6R3lwYkZJS2tzcDMwS29oZ2RKTjFHS2tmNm83c1JJUTFQQUliaGJVYXdqM1VJYlM2X0VJMktzOGZ1dDEtR0VWaTZaVE42MnNWazVRdjZGSGZIczlFbVdnc194Q2ZKdjRWeGpNcWk?oc=5","date":"2020-03-09","type":"pipeline","source":"Fierce Biotech","summary":"Arkin Holdings, Phoenix Group unite again on $140M biotech fund - Fierce Biotech","headline":"Arkin Holdings, Phoenix Group unite again on $140M biotech fund","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}